Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man

scientific article published on 01 January 2000

Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0021-9150(99)00220-8
P698PubMed publication ID10580169

P2093author name stringS Kapiotis
B Jilma
H G Eichler
T Pernerstorfer
P Stohlawetz
P2860cites workHemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupQ39522420
von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemiaQ40886823
Pharmacokinetics and haematological effects of desmopressinQ42513166
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteriesQ44139534
Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) StudyQ44734148
Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's diseaseQ45863842
Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).Q45879438
Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease.Q50867087
Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: relationship with von Willebrand factor.Q50953908
Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease.Q50994531
Sex differences in concentrations of exhaled nitric oxide and plasma nitrate.Q51040992
The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in manQ68065246
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosisQ68189712
Effects of desmopressin on circulating P-selectinQ71099056
Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular diseaseQ71781362
Factor VIII, ABO blood group and the incidence of ischaemic heart diseaseQ72403298
Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigenQ74263107
P433issue1
P304page(s)43-47
P577publication date2000-01-01
P1433published inAtherosclerosisQ4813570
P1476titlePartial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man
P478volume148

Reverse relations

cites work (P2860)
Q55312862Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins.
Q23909575Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries
Q28190911Pharmacological characteristics of solid-phase von Willebrand factor in human platelets
Q35193909Von Willebrand factor and oxidative stress parameters in acute coronary syndromes
Q28384869Von Willebrand factor and the right ventricle (the MESA-Right Ventricle Study)
Q61651374von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina

Search more.